apt medical inc. (688617): Performance basically meets expectations, bullish on product volume expansion under centralized procurement.

Event: On October 26, the company released its 2024 third-quarter report: In the first three quarters of 2024, revenue reached 1.525 billion yuan, a year-on-year increase of 25.63%; net income attributable to shareholders was 0.528 billion yuan year-on-year.

the pacific securitiesOct 31 00:00

apt medical inc. (688617) 2024 third quarter report review: income meets expectations, bullish on future growth

Investment Highlights: In the third quarter of 2024, the company announced that it achieved a total operating income of 1.525 billion yuan (+25.63%, year-on-year growth rate, the same below), with a net income attributable to the parent company of 0.528 billion yuan (+30.97%).

soochow securitiesOct 30 07:51

Express News | The HIERS multi-channel physiological recorder independently developed by the subsidiary of apt medical inc. has been approved for listing.

BreakingsOct 29 10:43

Third Quarter Report 2024

SZSIOct 26 00:00 · Announcements

apt medical inc. (688617.SH): net income for the first three quarters was 0.528 billion yuan, a year-on-year increase of 30.97%.

Gelonghui reported on October 25th that apt medical inc. (688617.SH) released its third-quarter report, with revenue of 1.52 billion yuan in the first three quarters, a year-on-year increase of 25.63%, net income of 0.528 billion yuan, a year-on-year increase of 30.97%, non-GAAP net income of 0.508 billion yuan, a year-on-year increase of 41.08%, and basic earnings per share of 5.44 yuan.

Gelonghui FinanceOct 25 21:36

Apt Medical Inc. (688617): The electrophysiology medical device has accumulated experience and the vascular intervention platform is becoming more perfect.

As a domestic leader in electrophysiology and vascular intervention, Mindray has settled in to empower research and development as well as sales at home and abroad. The company was established in 2002, initially focusing on electrophysiological equipment, and later expanding horizontally into areas such as coronary artery pathways, peripheral interventions, and non-vascular interventions.

Guosheng SecuritiesOct 9 16:46